MY183114A - Oral liquid composition - Google Patents

Oral liquid composition

Info

Publication number
MY183114A
MY183114A MYPI2017702777A MYPI2017702777A MY183114A MY 183114 A MY183114 A MY 183114A MY PI2017702777 A MYPI2017702777 A MY PI2017702777A MY PI2017702777 A MYPI2017702777 A MY PI2017702777A MY 183114 A MY183114 A MY 183114A
Authority
MY
Malaysia
Prior art keywords
oral liquid
liquid composition
composition
precipitate
sedimentation
Prior art date
Application number
MYPI2017702777A
Inventor
Yumiko Hirashima
Yasuhiro Akabane
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY183114A publication Critical patent/MY183114A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an oral liquid composition which is prepared by adding, to an oral liquid composition being free from ethanol and comprising potassium nitrate (A) and cetyl pyridinium chloride (B), a nonionic surfactant (C) and an amphoteric surfactant (D), wherein the content of water (E) is controlled to 55 wt% or higher and lower than 92 wt % and the pH of the composition is adjusted to 6.8 or higher and lower than 8.0. The oral liquid composition, wherein the sedimentation of an insoluble precipitate, said precipitate being formed by the combined use of the components (A) and (B) in the aforesaid oral liquid composition, is suppressed, has excellent effects of suppressing hypersensitivity and preventing dental caries.
MYPI2017702777A 2015-02-17 2016-02-16 Oral liquid composition MY183114A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015028458A JP6547324B2 (en) 2015-02-17 2015-02-17 Liquid oral composition
PCT/JP2016/054370 WO2016133063A1 (en) 2015-02-17 2016-02-16 Oral liquid composition

Publications (1)

Publication Number Publication Date
MY183114A true MY183114A (en) 2021-02-15

Family

ID=56689008

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017702777A MY183114A (en) 2015-02-17 2016-02-16 Oral liquid composition

Country Status (5)

Country Link
JP (1) JP6547324B2 (en)
KR (1) KR102491340B1 (en)
CN (1) CN107249546B (en)
MY (1) MY183114A (en)
WO (1) WO2016133063A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6688072B2 (en) * 2015-12-28 2020-04-28 花王株式会社 Liquid oral composition
CN110974724B (en) * 2019-12-30 2023-04-18 重庆登康口腔护理用品股份有限公司 Composition containing hyaluronic acid and preparation method and application thereof
WO2022255124A1 (en) * 2021-06-03 2022-12-08 ライオン株式会社 Liquid composition for oral use
JP2024093970A (en) * 2022-12-27 2024-07-09 アース製薬株式会社 Method for inhibiting precipitation of insoluble substances in liquid oral compositions, precipitation inhibitor, and liquid oral composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3863006A (en) 1973-01-29 1975-01-28 Milton Hodosh Method for desensitizing teeth
JPH0629177B2 (en) 1984-06-01 1994-04-20 ライオン株式会社 Oral composition
JP3117086B2 (en) * 1990-11-02 2000-12-11 サンスター株式会社 Oral liquid preparation
JPH07101842A (en) 1993-08-12 1995-04-18 Lion Corp Oral composition
JP3978609B2 (en) 2003-08-25 2007-09-19 ライオン株式会社 Oral composition and method for preventing precipitation of potassium lauryl sulfate in oral composition
JP2007084471A (en) 2005-09-21 2007-04-05 Sunstar Inc Composition for oral cavity and method of selecting product for oral cavity
WO2009020010A1 (en) * 2007-08-09 2009-02-12 Lion Corporation Liquid oral composition, and method for improvement in bactericidal activity of cationic bactericidal agent
JP2012121833A (en) * 2010-12-08 2012-06-28 Lion Corp Composition for oral cavity and agent for inhibiting fixing of oral cavity disease-causing bacillus to tooth plane
JP2013035792A (en) 2011-08-09 2013-02-21 Kao Corp Composition for oral cavity
JP5830324B2 (en) * 2011-09-21 2015-12-09 ライオン株式会社 Dentifrice composition
JP6138538B2 (en) * 2013-03-25 2017-05-31 サンスター株式会社 Transparent liquid composition for oral cavity

Also Published As

Publication number Publication date
JP2016150912A (en) 2016-08-22
JP6547324B2 (en) 2019-07-24
CN107249546A (en) 2017-10-13
KR102491340B1 (en) 2023-01-26
KR20170117406A (en) 2017-10-23
WO2016133063A1 (en) 2016-08-25
CN107249546B (en) 2020-07-10

Similar Documents

Publication Publication Date Title
MX2016011897A (en) Compositions of selenoorganic compounds and methods of use thereof.
MX383037B (en) Delivery of surfactant soluble anti-dandruff agent
MX372619B (en) Cosmetic cleansing compositions
EP4674483A3 (en) Compositions and methods for reducing ocular neovascularization
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
PH12017501033A1 (en) Oral care compositions and methods of use
MX2016007536A (en) Sulfate-free personal care cleansing compositions.
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
PH12019501193A1 (en) Use of chelating agents for improving color stability of resorcinol
MX2017013538A (en) Concentrated personal cleansing compositions and methods.
EA201791670A1 (en) HARD COMPOSITIONS FOR CARE OF THE ORAL CAVITY
MX2020006596A (en) Hydroxyisoxazolines and derivatives thereof.
MY193926A (en) Oral biofilm removing agent and oral composition
PH12018500695A1 (en) Oral care compositions and methods of using the compositions
MX2016003238A (en) Cationic antiseptic compositions.
EA027661B9 (en) Oral care compositions
ZA201802606B (en) Compositions for dental varnishes and methods of making and using same
EA201692149A1 (en) COMPOSITIONS FOR CARE OF THE ORAL CAVITY
EP4591929A3 (en) Use of nor-ursodeoxycholic acid for reducing liver fat
PH12015502526A1 (en) Oral care compositions
MY188028A (en) Sialylated glycoprotein compositions and uses thereof
MX2020012714A (en) Compositions and methods for increasing consumption of water in companion animals.
SG10201810093PA (en) Pharmaceutical composition for external use
PH12016501250B1 (en) Oral care compositions
MY191247A (en) Oral composition